Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS

HAE Stock Forecast, Price Targets, Chart, Dividends & Analysis

Haemonetics Corporation logo

Haemonetics Corporation

Sector: Healthcare   

Industry: Medical Instruments & Supplies

87.47
 
USD
  
-0.42
  
(-0.48%)
Previous close: 87.89  Open: 87.92  Bid: 84.33  Ask: 89.7
52 week range    
70.25   
   97.97
Mkt Cap: 4,446 M  Avg Vol (90 Days): 613,392
Peers   
TMO / 
SYK / 
BDX / 
CERS / 
BAX / 
PKI / 
JNJ / 
Last updated: Sunday 1st December 2024

Stock Rankings

62
MarketXLS Rank
65
Value
69
Technical
52
Quality
How are these ranks calculated?
Ad slot not ready
Search for a stock

Metrics

Peers

StockDividendMarket Cap (B)PEPrice ($)

BAX

0.020217 B145.333.71

BDX

0.018765 B46.4221.9

CERS

0 B-141.85

JNJ

0.032372 B26.14155.01

MDT

0.0324110 B28.8786.54

PKI

115.24

SYK

0.0082149 B41.26392.15

TMO

0.0029196 B32.24529.63
Financials

HAE Income Statement

Annual
Mar-15Mar-16Mar-17Mar-18Mar-19Mar-20Mar-21Mar-22Mar-23Mar-24
Amortization of intangibles-33 M-37 M-32 M211 M26 M-5 M467 M466 M565 M
Basic EPS from continuing operations1.071.511.570.852.272.32
Basic EPS total0.33-1.09-0.510.861.071.511.570.852.272.32
Basic weighted shares outstanding52 M51 M52 M53 M52 M51 M51 M51 M51 M51 M
Cost of sales476 M503 M508 M-492 M550 M504 M473 M488 M554 M618 M
Depreciation-53 M-66 M-58 M109 M110 M84 M98 M93 M97 M
Depreciation unreconciled-86 M-90 M-89 M26 M33 M
DepreciationAndAmortization-86 M-90 M-89 M109 M26 M84 M98 M93 M97 M
Diluted EPS total0.32-1.09-0.510.851.041.481.550.842.242.29
Diluted normalized net income/share1.041.481.550.842.242.29
Diluted weighted shares outstanding52 M51 M52 M54 M53 M52 M51 M51 M51 M51 M
GainOnSaleOfBusiness-289000.010 M
GainOnSaleOfPPE8 M8 M-10 M-382000.0-2 M
GainOnSaleOfSecurity8 M
GainsLossOnDisposalOfDiscontinuedOperations8 M33 M10 M382000.02 M
GeneralAndAdministrativeExpense-6 M-6 M-6 M298 M282 M274 M340 M377 M432 M
Gross operating profit434 M406 M378 M412 M418 M485 M398 M506 M615 M692 M
ImpairmentOfCapitalAssets-16 M-75 M-4 M
Income before tax31 M-53 M-27 M60 M74 M87 M73 M64 M141 M152 M
Income restructuring and M&A-37 M-22 M-31 M21 M26 M1 M4 M657000.014 M
Income taxes14 M2 M-1 M14 M19 M11 M-7 M20 M26 M34 M
InterestExpenseNonOperating13 M14 M17 M6 M13 M20 M
InterestExpenseOperating-8 M-8 M-8 M-13 M
MiscOtherSpecialCharges-9 M-9 M-8 M899 M-10 M-16 M-17 M-17 M-15 M-13 M
Net income from total operations17 M-56 M-26 M46 M55 M77 M79 M43 M115 M118 M
NetIncomeCommonStockholders17 M-56 M-26 M46 M55 M77 M79 M43 M115 M118 M
NetIncomeContinuousOperations17 M-56 M-26 M46 M55 M77 M79 M81 M148 M148 M
NetIncomeDiscontinuousOperations8 M33 M10 M382000.02 M
NetNonOperatingInterestIncomeExpense200000.0300000.0300000.0-13 M-13 M-9 M-6 M-13 M-19 M
NonRecurringOperationExpense-3 M3 M-8 M-897000.0-1 M-5 M-7 M
Normalized income60 M170 M
Operating income43 M44 M39 M-848 M84 M103 M90 M81 M156 M165 M
Operating income before depreciation (EBITDA)109 M36 M54 M141 M211 M174 M208 M282 M305 M
OperatingExpense391 M362 M339 M-356 M334 M381 M308 M425 M459 M527 M
Other income net12 M97 M67 M-907 M10 M67 M18 M17 M15 M23 M
OtherGandA-6 M-6 M-6 M298 M282 M274 M340 M377 M432 M
OtherImpairmentOfCapitalAssets5 M92 M59 M-2 M21 M51 M1 M577000.010 M
OtherOperatingExpenses-5 M-2 M-282000.0-6 M-33 M-3 M-4 M-234000.0
OtherWriteOff478000.0607000.0110000.0166000.077000.0
PromotionAndAdvertising-4 M-2 M-3 M5 M4 M3 M4 M7 M7 M
RentAndLandingFees-6 M-6 M-6 M6 M
Research & development expense54 M45 M38 M39 M36 M31 M33 M47 M50 M54 M
ResearchExpense54 M45 M38 M39 M36 M31 M33 M47 M50 M54 M
RestructringAndMnAIncome-37 M-22 M-31 M21 M26 M1 M4 M657000.014 M
Revenue per share-64 M-64 M-58 M186 M26 M-5 M467 M466 M565 M
SalariesAndWages-14 M-9 M-13 M3 M7 M2 M2 M1 M1 M
Selling Gen & administrative expense337 M317 M302 M317 M298 M282 M274 M340 M377 M432 M
SellingAndMarketingExpense337 M317 M302 M317 M5 M4 M3 M4 M7 M7 M
SellingExpense337 M317 M302 M317 M
Special income/charges53 M97 M38 M-21 M-13 M-547000.0-3 M5 M-7 M
Total Income available for interest expense (EBIT)23 M-53 M-35 M52 M101 M90 M107 M187 M201 M
Total common shares outstanding52 M51 M52 M52 M51 M50 M51 M51 M51 M51 M
Total net income17 M-56 M-26 M46 M55 M77 M79 M43 M115 M118 M
Total ordinary shares51 M51 M51 M51 M51 M51 M51 M51 M51 M51 M
Total revenues910 M909 M886 M904 M968 M988 M870 M993 M1,169 M1,309 M
TotalExpenses867 M865 M847 M-848 M884 M885 M781 M912 M1,013 M1,144 M
TotalRevenue910 M909 M886 M904 M968 M988 M870 M993 M1,169 M1,309 M
WriteDown-5 M
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and templates.

MarketXLS is a complete Excel stock solution

Kevin Hsu

StockKevin.com

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel

Lloyd Lenase

Option Day Trader

MarketXLS is a data junkie’s dream. It gives me the flexibility to mine for hidden treasures.

Dave

Swing trader since 2011

I like to access historical closing prices on a particular date. That makes tracking performance easy.

Patrick Cusatis, Ph.D., CFA

Associate Professor of Finance - Penn State University